Dialysis prescription

Reading File

Finding Sources

Reading File

Dialysis prescription is a broad topic covering both hemodialysis (HD) and peritoneal dialysis (PD). Here's a map of what it involves, based on Brenner and Rector's The Kidney and Comprehensive Clinical Nephrology:

Topic Breakdown

Hemodialysis (HD) prescription components - duration, frequency, vascular access, dialyzer choice, blood/dialysate flow rates, ultrafiltration rate, dialysate composition, anticoagulation, dialysate temperature, intradialytic medications
Peritoneal dialysis (PD) prescription components - exchange volume, dwell time, number of exchanges, dialysate glucose/osmotic strength, CAPD vs APD selection
Dialysis adequacy and dosing - Kt/V, urea reduction ratio (URR), residual kidney function (Ku), targets for adequate clearance
Choosing between HD and PD - patient selection factors, comparing clearance doses, contraindications
Special situations - acute kidney injury dialysis prescription, pediatric or pregnant patients, hemodynamically unstable patients (CRRT/SLED)

Brief Overview

The goal of any dialysis prescription is to replace excretory kidney function: clearing solutes (urea, potassium, phosphorus), correcting acid-base balance (via bicarbonate in dialysate), and removing excess fluid volume (ultrafiltration), while individualizing the regimen to the patient's metabolic rate, nutritional status, and residual kidney function.

For hemodialysis, the prescription is built from components in Box 63.1 of Brenner and Rector's The Kidney: session duration and frequency, vascular access type, dialyzer membrane/surface area, blood and dialysate flow rates, ultrafiltration rate, dialysate composition (sodium, potassium, calcium, bicarbonate, glucose), anticoagulation strategy, dialysate temperature, and any intradialytic medications. Adequacy is typically judged using Kt/V (a measure of urea clearance relative to body water) or the urea reduction ratio.

For peritoneal dialysis, the prescription instead specifies exchange (dwell) volume, dwell time, number of exchanges per day, and the dextrose/icodextrin concentration of the dialysate to control ultrafiltration, delivered either manually (CAPD) or via a cycler (APD).

Choice between modalities depends on patient factors (cardiovascular stability, residual function, home support, prior abdominal surgery, patient preference) rather than one being universally superior - - Brenner and Rector's The Kidney, p. Ch. 63.

Which of these would you like me to go into detail on?

Asking for Preferences

Which aspect of dialysis prescription do you want to go deep on?

Dialysis prescription is a broad topic covering both hemodialysis (HD) and peritoneal dialysis (PD). Here's a map of what it involves, based on Brenner and Rector's The Kidney and Comprehensive Clinical Nephrology:

Topic Breakdown

Hemodialysis (HD) prescription components - duration, frequency, vascular access, dialyzer choice, blood/dialysate flow rates, ultrafiltration rate, dialysate composition, anticoagulation, dialysate temperature, intradialytic medications
Peritoneal dialysis (PD) prescription components - exchange volume, dwell time, number of exchanges, dialysate glucose/osmotic strength, CAPD vs APD selection
Dialysis adequacy and dosing - Kt/V, urea reduction ratio (URR), residual kidney function (Ku), targets for adequate clearance
Choosing between HD and PD - patient selection factors, comparing clearance doses, contraindications
Special situations - acute kidney injury dialysis prescription, pediatric or pregnant patients, hemodynamically unstable patients (CRRT/SLED)

Brief Overview

The goal of any dialysis prescription is to replace excretory kidney function: clearing solutes (urea, potassium, phosphorus), correcting acid-base balance (via bicarbonate in dialysate), and removing excess fluid volume (ultrafiltration), while individualizing the regimen to the patient's metabolic rate, nutritional status, and residual kidney function.

For hemodialysis, the prescription is built from components in Box 63.1 of Brenner and Rector's The Kidney: session duration and frequency, vascular access type, dialyzer membrane/surface area, blood and dialysate flow rates, ultrafiltration rate, dialysate composition (sodium, potassium, calcium, bicarbonate, glucose), anticoagulation strategy, dialysate temperature, and any intradialytic medications. Adequacy is typically judged using Kt/V (a measure of urea clearance relative to body water) or the urea reduction ratio.

For peritoneal dialysis, the prescription instead specifies exchange (dwell) volume, dwell time, number of exchanges per day, and the dextrose/icodextrin concentration of the dialysate to control ultrafiltration, delivered either manually (CAPD) or via a cycler (APD).

Choice between modalities depends on patient factors (cardiovascular stability, residual function, home support, prior abdominal surgery, patient preference) rather than one being universally superior - - Brenner and Rector's The Kidney, p. Ch. 63.

Which of these would you like me to go into detail on?It looks like I tried to use a clarification tool that isn't actually available in this session. Let me just lay out the breakdown directly as text.

Dialysis Prescription - Topic Map

Hemodialysis (HD) prescription components - duration, frequency, vascular access, dialyzer choice, blood/dialysate flow rates, ultrafiltration rate, dialysate composition, anticoagulation, dialysate temperature, intradialytic medications
Peritoneal dialysis (PD) prescription components - exchange volume, dwell time, number of exchanges, dialysate glucose/osmotic agent strength, CAPD vs APD
Dialysis adequacy and dosing - Kt/V, urea reduction ratio (URR), residual kidney function (Ku)
Choosing between HD and PD - patient selection factors, comparing clearance doses, contraindications
Special situations - acute kidney injury dialysis prescription, pediatric/pregnant patients, hemodynamically unstable patients (CRRT/SLED)

Brief Overview

The goal of any dialysis prescription is to replace excretory kidney function: clearing solutes (urea, potassium, phosphorus), correcting acid-base balance via bicarbonate in the dialysate, and removing excess fluid volume through ultrafiltration - all individualized to the patient's metabolic rate, nutritional status, and residual kidney function.

For hemodialysis, per Brenner and Rector's The Kidney (Box 63.1), the prescription is built from: session duration and frequency, vascular access type, dialyzer membrane/surface area, blood and dialysate flow rates, ultrafiltration rate, dialysate composition (sodium, potassium, calcium, bicarbonate, glucose), anticoagulation strategy, dialysate temperature, and intradialytic medications. Adequacy is judged with Kt/V or the urea reduction ratio.

For peritoneal dialysis, the prescription specifies exchange (dwell) volume, dwell time, number of exchanges per day, and the dextrose/icodextrin concentration of the dialysate to control ultrafiltration, delivered manually (CAPD) or by cycler (APD).

The choice between modalities depends on patient factors - cardiovascular stability, residual kidney function, home support, prior abdominal surgery, and patient preference - rather than one modality being universally superior - Brenner and Rector's The Kidney, Ch. 63.

Which of these five topics would you like me to go deep on? (Or let me know if you had a more specific question about dialysis prescription in mind.)

Explain how to calculate Kt/V and interpret dialysis adequacy

Finding Sources

Reading File

Finding Sources

Searching PubMed

"Kt/V" AND hemodialysis adequacy

Kt/V: What It Measures

Kt/V is a dimensionless index of dialysis dose for urea, the standard marker of small-solute clearance.

K = urea clearance of the dialyzer (or peritoneal membrane, or native kidney) in mL/min or L/hr
t = duration of treatment (hours)
V = volume of distribution of urea, which approximates total body water (liters)

A Kt/V of 1.0 means a volume of plasma equal to the patient's total body water has been completely cleared of urea during the session - not that all urea has been removed, because urea re-equilibrates between body compartments during and after dialysis (Comprehensive Clinical Nephrology, 7th ed., "Single-Pool Kt/V and Equilibrated Kt/V").

How It's Calculated

1. Urea Reduction Ratio (URR) - the simplest estimate

URR = (C0 - C) / C0 x 100%

where C0 = predialysis BUN, C = postdialysis BUN. Easy to calculate but doesn't account for urea generation, ultrafiltration, or urea rebound after treatment. A minimum URR of 65-70% is considered adequate for a standard thrice-weekly HD session - Comprehensive Clinical Nephrology, 7th ed.

2. Single-pool Kt/V (spKt/V) - the Daugirdas equation, the standard clinical formula:

spKt/V = -ln(R - 0.008 x t) + (4 - 3.5R) x UF/W

where:

R = C/C0 (postdialysis BUN / predialysis BUN)
t = session length in hours
UF = ultrafiltration volume (liters)
W = postdialysis body weight (kg)

This is more accurate than URR because it incorporates ongoing urea generation during dialysis and the extra clearance gained from fluid removal (ultrafiltration) - Comprehensive Clinical Nephrology, 7th ed., Table 99-1.

3. Equilibrated Kt/V (eKt/V) corrects spKt/V for post-dialysis urea rebound (urea shifting from tissue back into blood after treatment ends), since blood is drawn immediately post-dialysis before full equilibration:

Arteriovenous access: eKt/V = spKt/V - (0.6 x spKt/V/t) + 0.03
Central venous catheter access: eKt/V = spKt/V - (0.47 x spKt/V/t) + 0.02

eKt/V is always somewhat lower than spKt/V because it accounts for the "rebound" rise in BUN.

4. Weekly standard Kt/V (stdKt/V) converts intermittent thrice-weekly clearance into an equivalent continuous clearance, so it can be compared directly with continuous therapies (CRRT, peritoneal dialysis) or residual native kidney clearance. This uses the eKt/V plus treatment frequency, read off a nomogram/curve rather than a simple algebraic formula - Comprehensive Clinical Nephrology, 7th ed., Fig. 99.2.

Peritoneal dialysis Kt/V is calculated differently, from effluent rather than blood sampling:

Peritoneal Kt/V = (24-hr PD effluent urea / plasma urea) / V
Kidney Kt/V = (24-hr urine urea / plasma urea) / V
Daily total Kt/V = peritoneal Kt/V + kidney Kt/V
Weekly Kt/V = daily Kt/V x 7
National Kidney Foundation Primer on Kidney Diseases, 8th ed., Table 57.7

Interpreting Adequacy

Modality	Target	Notes
Thrice-weekly HD	Delivered spKt/V ≥ 1.2 per session (URR ≥ 65-70%)	No added benefit from routinely increasing frequency beyond 3x/week once this is met - Brenner and Rector's The Kidney
Any-frequency HD (comparative)	Minimum weekly stdKt/V ≥ 2.1	Allows comparison across conventional, short daily, and nocturnal schedules
Peritoneal dialysis	Historically weekly Kt/V ~2.0 was targeted	Recent studies have not shown clear outcome benefit from chasing higher absolute Kt/V targets in PD, so the value is now interpreted alongside clinical status, volume control, and residual kidney function rather than as an isolated number - Comprehensive Clinical Nephrology, 7th ed.

Key interpretive points:

URR and Kt/V correlate curvilinearly, not linearly. Doubling Kt/V from 1.5 to 3.0 per session only raises URR from about 75% to 85%, so URR becomes insensitive at higher clearances and is a poor tool once dialysis is already fairly efficient (Brenner and Rector's The Kidney, Fig. 63.25).
Ultrafiltration matters. Both spKt/V and URR are affected by fluid removed during the session; the Daugirdas equation's UF/W term corrects for the extra convective clearance this provides.
Residual kidney function (Ku) should be added in when present, since native clearance contributes materially to total solute removal and its preservation is itself a goal of the prescription - underuse of Ku in dosing is called out as common in incident HD patients.
Access type affects rebound correction (AV fistula/graft vs. central catheter use different eKt/V correction constants), because recirculation and cardiopulmonary recirculation differ by access.
Below-target Kt/V should prompt review of session length/frequency, blood and dialysate flow rates, dialyzer clearance (surface area/membrane), access recirculation, or errors in blood sampling technique, rather than immediately concluding the patient is under-dialyzed.

I ran a quick check for recent evidence on Kt/V and hemodialysis adequacy; the top systematic reviews from the last 2 years covered hemodiafiltration vs. hemodialysis mortality, frequent vs. standard hemodialysis, and inspiratory muscle training, none of which contradict the calculation methods or targets above (PMIDs 39438899, 39240930, 40259454) - they're adjacent topics rather than direct updates to Kt/V methodology itself.